A blog maintained by an investor in Immune Response Corporation now called Orchestra Therapeutics, Inc. (OCHTQ.PK). Immune Response BioPharma claims to now own the research and trial results from Immune Response and is attempting to market their findings through the Immune Response BioPharma name.
Monday, March 12, 2012
Recent appointments at Immune Response Biopharma
At one time David Buswell said the the former executives at Immune Response Inc. aka Orchestra Therapeutic caused the companies failure and not the research. I find it interesting that now many of those some people are members of the new Immune Response BioPharma. My belief is that these are the people behind Immune Response Biopharma and that they deliberately caused the company to go bankrupt in order to take the research and start a new company called Immune Response BioPharma so they could dump all the previous investors, start a new company, and reap all the profits for themselves. I suspect it is only a matter of time till we hear that Kevin Kimberlin and Spencer Trask are now involved in the new Immune Response BioPharma.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment